Government restricts companies with an end to decades-old special exception for syrups
Suspense Crime, Digital Desk : Drugs Rules: In a significant step to check the spread of adulterated drugs, the center has removed cough syrups and liquid drugs from Schedule K ending decades-old special exemption.
Cough Syrup New Rules in India: Whenever someone falls ill with a cold or cough or fever-both children and adults-syrups or oral liquid drugs are the very first things consumed by the family. These drugs are taken in a liquid form and are readily available in almost every household. But have you ever stopped to think if the syrup you are administering to your child is perfectly safe? With an aim to stop the prevalence of substandard or adulterated drugs in the market, the central government has decided to take strong action.
The government has completely done away with the special exemption given for decades for the manufacturing of syrups or liquid drugs. Now pharmaceutical companies will be dealing with even stricter rules. The Ministry of Health and Family Welfare passed a new notification on the official gazette on June 9, 2026, that implements tougher restrictions on pharmaceutical companies.
What is the decision taken by the government?
Under the Drugs Rules, 1945, the government has brought about its fifth amendment. This means that the term 'syrup' is removed from a special list called Schedule K. In a simple sense, syrup manufacturers will no longer get to do as they pleased. They will have to face several quality tests and comply with several rules before their drugs make it to the market. The new amendment means that all cough syrups and other liquid drugs manufactured in the country will now undergo same harsh testing as other drugs like tablets or injections.
What is Schedule K and why was there special exception for syrups?
Schedule K was a list of drugs under the Indian Drugs Act which are exempt from certain Government regulations under this act:
Licensing exemption: drugs mentioned in this list get exemption from strict licensing provisions under the Drugs Act.
Labeling and packaging exemption: the packaging and labeling of syrup bottles were a bit liberal.
Easy manufacturing: taking advantage of this list, the small non-standard firms in India were manufacturing and selling various syrups that did not undergo thorough tests.
Taking away syrup from this list means thisVIP treatment has come to an end.
Why had the government take this action?
This stringent move has been taken following certain unfortunate and grave incidents that have tarnished the image of the Indian pharmaceutical industry globally. Back in 2022-23, children were reported dead in Gambia and Uzbekistan, as investigations stated that the drugs were a result of cough syrups manufactured in India by firms Marion Biotech and Maiden Pharmaceuticals which contained toxic substances.
Following this report, the Indian government, the Ministry of Health, and the Drug Controller General of India(DCGI) immediately went into a red alert and increased surveillance on the pharmaceutical firms to stop such an event from ever repeating. The latest amendment is a testament to this.
What is the impact of the decision on common people and patients?
The most significant impact will directly be seen on the common man and patients. The substandard and adulterated cough syrups will now completely disappear from the market. Now each and every syrup would be quality checked to prevent any side-effects and further loss of lives. The labeling and information on medicine bottles will also be more specific.
What will be the effect on pharmaceutical companies?
The latest amendment directly affects pharmaceutical firms producing syrup and liquid drugs. They will now be subject to many more regulations while manufacturing, labeling, and packaging of these drugs. Experts say this will bring an end to the menace of adulterated and substandard liquid drugs in the market and provide patients with a better and safer medicine.
